
    
      The study is a single arm, prospective, non-randomized, multi-center clinical investigation.

      The objective of this study is to evaluate the safety and effectiveness of the 15mm MHV in
      subjects five years or less of age with a diseased, damaged, or malfunctioning mitral heart
      valve. The objective will be evaluated by assessing valve-related adverse events, subject
      survival, subject growth, and echocardiogram assessment of hemodynamic function through the
      five year follow-up visit as long as the valve remains implanted.
    
  